Add Yahoo as a preferred source to see more of our stories on Google. Moving forward NHS England is set to offer thousands of men with prostate cancer a form of targeted radiation therapy for the ...

Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...

Eligible men with early prostate cancer are to be offered a new form of high-precision radiotherapy on the NHS for the first time — one that delivers a higher dose directly to the tumour while sparing ...

Add Yahoo as a preferred source to see more of our stories on Google. The once-daily pill, with its brand name Talzenna and produced by Pfizer, offers a crucial at-home treatment option after ...

NHS England has given the green light for abiraterone to be used to treat men with prostate cancer that has not metastasised. It is the first time the drug will be available for these patients in ...

The Independent and Yahoo will earn a commission from purchases made via links in this article. Pricing and availability are subject to change. Thousands of men with prostate cancer in England will be ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

India, Aug. 15 -- Middle-aged men in the UK could face tighter access to prostate cancer testing under new NHS guidance that gives GPs greater control over who should receive a prostate-specific ...

Learn how prostate cancer is treated at each stage, from active surveillance and surgery to radiation, hormone therapy, and targeted drugs.

NHS England is set to offer thousands of men with prostate cancer a form of targeted radiation therapy for the first time, mitigating the disease’s side effects while sparing eligible patients 15 ...